Fig. 3.
Secondary outcome of survival without HCC in patients with surveillance of both severe fibrosis (F3) and cirrhosis (F4).
Relative number of LCR1 and LCR2 assessments and number of patients needed to screen 1 HCC. Compared with the ‘cirrhosis-only’ option, assessing LCR2 in F3 and cirrhosis decreased the NNS of LCR2 by 32.0% from 2,702 when cirrhosis-only was the first step to 1,838. HCC, hepatocellular carcinoma; LCR, Liver Cancer Risk; NNS, number needed to screen.